{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:09:18Z","timestamp":1790075358812,"version":"4.0.1"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["091857\/Z\/10\/Z"],"award-info":[{"award-number":["091857\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106241\/Z\/14\/Z"],"award-info":[{"award-number":["106241\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L009846\/1"],"award-info":[{"award-number":["BB\/L009846\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J003018\/1"],"award-info":[{"award-number":["BB\/J003018\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L004275\/1"],"award-info":[{"award-number":["BB\/L004275\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C45605\/A16016"],"award-info":[{"award-number":["C45605\/A16016"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8717\/A18245"],"award-info":[{"award-number":["C8717\/A18245"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/12\/33\/29546"],"award-info":[{"award-number":["PG\/12\/33\/29546"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.mam.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T18:33:59Z","timestamp":1452537239000},"page":"54-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Pharmacological targeting of the HIF hydroxylases \u2013 A new field in medicine development"],"prefix":"10.1016","volume":"47-48","author":[{"given":"Mun Chiang","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Holt-Martyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.sbi.2012.10.001","article-title":"Role of the jelly-roll fold in substrate binding by 2-oxoglutarate oxygenases","volume":"22","author":"Aik","year":"2012","journal-title":"Curr. Opin. Struct. Biol"},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0020","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1021\/jm400193d","article-title":"Structural basis for inhibition of the fat mass and obesity associated protein (FTO)","volume":"56","author":"Aik","year":"2013","journal-title":"J. Med. Chem"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0025","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/nar\/gku085","article-title":"Structure of human RNA N6-methyladenine demethylase ALKBH5 provides insights into its mechanisms of nucleic acid recognition and demethylation","volume":"42","author":"Aik","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.mam.2016.01.001_bib0030","first-page":"59","article-title":"Introduction to structural studies on 2-oxoglutarate-dependent oxygenases and related enzymes, 2-oxoglutarate-dependent oxygenases","author":"Aik","year":"2015","journal-title":"R. Soc. Chem"},{"issue":"49","key":"10.1016\/j.mam.2016.01.001_bib9010","doi-asserted-by":"crossref","first-page":"42027","DOI":"10.1074\/jbc.M111.303222","article-title":"Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins","volume":"286","author":"Anderson","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng1019","article-title":"Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia","volume":"32","author":"Ang","year":"2002","journal-title":"Nat. Genet"},{"issue":"37","key":"10.1016\/j.mam.2016.01.001_bib0040","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.1074\/jbc.M406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2 and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J. Biol. Chem"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.2007.62","article-title":"Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism","volume":"40","author":"Aragones","year":"2008","journal-title":"Nat. Genet"},{"issue":"47","key":"10.1016\/j.mam.2016.01.001_bib0050","doi-asserted-by":"crossref","first-page":"33571","DOI":"10.1074\/jbc.M113.482364","article-title":"A knockin mouse model of human PHD2-associated erythrocytosis establishes a haploinsufficiency mechanism","volume":"288","author":"Arsenault","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0960","author":"Astellas Pharma Inc."},{"key":"10.1016\/j.mam.2016.01.001_bib0965","author":"Astellas Pharma Inc."},{"key":"10.1016\/j.mam.2016.01.001_bib0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/41.3.8429197","article-title":"Co-localization of erythropoietin messenger RNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin","volume":"41","author":"Bachmann","year":"1993","journal-title":"J. Histochem. Cytochem"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FJC.0b013e3181e2bfef","article-title":"Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat","volume":"56","author":"Bao","year":"2010","journal-title":"J. Cardiovasc. Pharmacol"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0065","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/mol.110.070508","article-title":"Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor","volume":"79","author":"Barrett","year":"2011","journal-title":"Mol. Pharmacol"},{"issue":"16","key":"10.1016\/j.mam.2016.01.001_bib0070","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1111\/bph.13188","article-title":"Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats","volume":"172","author":"Barrett","year":"2015","journal-title":"Br. J. Pharmacol"},{"issue":"19","key":"10.1016\/j.mam.2016.01.001_bib0075","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJM194905122401903","article-title":"Erythropoietic effect of cobalt in patients with or without anemia","volume":"240","author":"Berk","year":"1949","journal-title":"NEJM"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0080","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2005121302","article-title":"Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure","volume":"17","author":"Bernhardt","year":"2006","journal-title":"J. Am. Soc. Nephrol"},{"issue":"50","key":"10.1016\/j.mam.2016.01.001_bib0085","doi-asserted-by":"crossref","first-page":"21276","DOI":"10.1073\/pnas.0903978106","article-title":"Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model","volume":"106","author":"Bernhardt","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0090","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J. Am. Soc. Nephrol"},{"issue":"16","key":"10.1016\/j.mam.2016.01.001_bib0095","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"NEJM"},{"key":"10.1016\/j.mam.2016.01.001_bib0105","article-title":"Roxadustat (FG-4592): correction of anemia in incident dialysis patients","author":"Besarab","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"issue":"10","key":"10.1016\/j.mam.2016.01.001_bib0110","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","article-title":"Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients","volume":"30","author":"Besarab","year":"2015","journal-title":"Nephrol. Dial. Transplant"},{"issue":"52","key":"10.1016\/j.mam.2016.01.001_bib0115","doi-asserted-by":"crossref","first-page":"36542","DOI":"10.1074\/jbc.M804578200","article-title":"The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF","volume":"283","author":"Beyer","year":"2008","journal-title":"J. Biol. Chem"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCRESAHA.117.305109","article-title":"HIF hydroxylase pathways in cardiovascular physiology and medicine","volume":"117","author":"Bishop","year":"2015","journal-title":"Circ. Res"},{"issue":"49","key":"10.1016\/j.mam.2016.01.001_bib0125","doi-asserted-by":"crossref","first-page":"19426","DOI":"10.1073\/pnas.0805230105","article-title":"Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice","volume":"105","author":"Botusan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2007111181","article-title":"The effect of altitude on dosing and response to erythropoietin in ESRD","volume":"19","author":"Brookhart","year":"2008","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1016\/j.mam.2016.01.001_bib0135","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0140","doi-asserted-by":"crossref","first-page":"e0132004","DOI":"10.1371\/journal.pone.0132004","article-title":"Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jnc.12804","article-title":"HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice","volume":"131","author":"Chen","year":"2014","journal-title":"J. Neurochem"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2005.09.041","article-title":"A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases","volume":"337","author":"Cho","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0155","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1124\/mol.105.015271","article-title":"Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger","volume":"68","author":"Choi","year":"2005","journal-title":"Mol. Pharmacol"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/embr.201337642","article-title":"Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2","volume":"15","author":"Choudhry","year":"2014","journal-title":"EMBO Rep"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.str.2009.06.002","article-title":"Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases","volume":"17","author":"Chowdhury","year":"2009","journal-title":"Structure"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0170","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1021\/cb400088q","article-title":"Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases","volume":"8","author":"Chowdhury","year":"2013","journal-title":"ACS Chem. Biol"},{"issue":"41","key":"10.1016\/j.mam.2016.01.001_bib0175","doi-asserted-by":"crossref","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1074\/mcp.M800340-MCP200","article-title":"Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins","volume":"8","author":"Cockman","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2016.01.001_bib0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2009.05042.x","article-title":"FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins","volume":"1177","author":"Cockman","year":"2009","journal-title":"Ann. N. Y. Acad. Sci"},{"issue":"33","key":"10.1016\/j.mam.2016.01.001_bib0190","doi-asserted-by":"crossref","first-page":"24027","DOI":"10.1074\/jbc.M704102200","article-title":"Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor","volume":"282","author":"Coleman","year":"2007","journal-title":"J. Biol. Chem"},{"issue":"48","key":"10.1016\/j.mam.2016.01.001_bib9015","doi-asserted-by":"crossref","first-page":"18154","DOI":"10.1073\/pnas.0602235103","article-title":"Prolyl hydroxylase-1 negatively regulates I\u03baB kinase-beta, giving insight into hypoxia-induced NF\u03baB activity","volume":"103","author":"Cummins","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib0195","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1073\/pnas.082121399","article-title":"Structural basis for hif-1\u03b1\/CBP recognition in the cellular hypoxic response","volume":"99","author":"Dames","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0200","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.mam.2016.01.001_bib0205","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1073\/pnas.202614999","article-title":"Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway","volume":"99","author":"Dann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ab.2008.09.052","article-title":"Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology","volume":"384","author":"Dao","year":"2009","journal-title":"Anal. Biochem"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0215","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1158\/0008-5472.CAN-05-4564","article-title":"The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha","volume":"66","author":"Dayan","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0220","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jtbi.2009.03.009","article-title":"Gene regulation in response to graded hypoxia: the non-redundant roles of the oxygen sensors PHD and FIH in the HIF pathway","volume":"259","author":"Dayan","year":"2009","journal-title":"J. Theor. Biol"},{"issue":"27","key":"10.1016\/j.mam.2016.01.001_bib0225","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1002\/anie.201202000","article-title":"Dynamic combinatorial chemistry employing boronic acids\/boronate esters leads to potent oxygenase inhibitors","volume":"51","author":"Demetriades","year":"2012","journal-title":"Angew. Chem. Int. Ed Engl"},{"key":"10.1016\/j.mam.2016.01.001_bib0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/1743-422X-8-477","article-title":"Regulation of the HIV-1 promoter by HIF-1alpha and Vpr proteins","volume":"8","author":"Deshmane","year":"2011","journal-title":"Virol. J."},{"issue":"Suppl. 7","key":"10.1016\/j.mam.2016.01.001_bib0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/16.suppl_7.25","article-title":"Hyporesponsiveness to recombinant human erythropoietin","volume":"16","author":"Dr\u00fceke","year":"2001","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.mam.2016.01.001_bib0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BJ20061151","article-title":"Studies on the activity of the hypoxia-inducible factor hydroxylases using an oxygen consumption assay","volume":"401","author":"Ehrismann","year":"2007","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0245","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1074\/jbc.C200644200","article-title":"Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha","volume":"278","author":"Elkins","year":"2003","journal-title":"J. Biol. Chem"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"NEJM"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0255","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion [mdash] from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0260","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nrd4422","article-title":"Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases","volume":"13","author":"Eltzschig","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.mam.2016.01.001_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.mam.2016.01.001_bib0270","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.1021\/bi300229y","article-title":"Inverse solvent isotope effects demonstrate slow aquo release from hypoxia inducible factor-prolyl hydroxylase (PHD2)","volume":"51","author":"Flagg","year":"2012","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0275","doi-asserted-by":"crossref","first-page":"e111838","DOI":"10.1371\/journal.pone.0111838","article-title":"Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85\u20133934 (Molidustat) stimulates erythropoietin production without hypertensive effects","volume":"9","author":"Flamme","year":"2014","journal-title":"PLoS ONE"},{"issue":"19","key":"10.1016\/j.mam.2016.01.001_bib0280","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1111\/j.1742-4658.2010.07804.x","article-title":"Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen","volume":"277","author":"Flashman","year":"2010","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrd2761","article-title":"Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease","volume":"8","author":"Fraisl","year":"2009","journal-title":"Nat. Rev. Drug Discov"},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib0290","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1073\/pnas.082117899","article-title":"Structural basis for recruitment of CBP\/p300 by hypoxia-inducible factor-1\u03b1","volume":"99","author":"Freedman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0295","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.193.9.1027","article-title":"Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia","volume":"193","author":"Furuta","year":"2001","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0300","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI77701","article-title":"HIF2alpha signaling inhibits adherens junctional disruption in acute lung injury","volume":"125","author":"Gong","year":"2015","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0310","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jmb.2009.07.070","article-title":"Asparaginyl beta-hydroxylation of proteins containing ankyrin repeat domains influences their stability and function","volume":"392","author":"Hardy","year":"2009","journal-title":"J. Mol. Biol"},{"key":"10.1016\/j.mam.2016.01.001_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10409230490440541","article-title":"Fe(II)\/alpha-ketoglutarate-dependent hydroxylases and related enzymes","volume":"39","author":"Hausinger","year":"2004","journal-title":"Crit. Rev. Biochem. Mol. Biol"},{"key":"10.1016\/j.mam.2016.01.001_bib0320","first-page":"1","article-title":"Biochemical diversity of 2-oxoglutarate-dependent oxygenases, 2-oxoglutarate-dependent oxygenases","author":"Hausinger","year":"2015","journal-title":"R. Soc. Chem"},{"issue":"29","key":"10.1016\/j.mam.2016.01.001_bib0325","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family","volume":"277","author":"Hewitson","year":"2002","journal-title":"J. Biol. Chem"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0330","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.M608337200","article-title":"Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates","volume":"282","author":"Hewitson","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0076-6879(07)35002-7","article-title":"Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2","volume":"435","author":"Hewitson","year":"2007","journal-title":"Methods Enzymol"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0340","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J. Clin. Invest"},{"issue":"13","key":"10.1016\/j.mam.2016.01.001_bib0345","doi-asserted-by":"crossref","first-page":"30772","DOI":"10.1074\/jbc.M304982200","article-title":"Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor HIF","volume":"278","author":"Hirsila","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0350","article-title":"Four-week studies of oral hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 for treatment of anemia","author":"Holdstock","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"issue":"13","key":"10.1016\/j.mam.2016.01.001_bib0355","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1074\/jbc.M110.186809","article-title":"Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury","volume":"286","author":"Holscher","year":"2011","journal-title":"J. Biol. Chem"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0360","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1182\/blood-2007-02-073254","article-title":"HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques","volume":"110","author":"Hsieh","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib9020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2012.09.005","article-title":"Prolyl hydroxylase domain protein 2 regulates the intracellular cyclic AMP level in cardiomyocytes through its interaction with phosphodiesterase 4D","volume":"427","author":"Huo","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"18","key":"10.1016\/j.mam.2016.01.001_bib0370","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1074\/jbc.M109.084855","article-title":"Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury","volume":"285","author":"Hyvarinen","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0375","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.mam.2016.01.001_bib0380","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.192342099","article-title":"Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor","volume":"99","author":"Ivan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5516","key":"10.1016\/j.mam.2016.01.001_bib0385","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"issue":"Pt 6","key":"10.1016\/j.mam.2016.01.001_bib0390","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J. Physiol"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cpdd.83","article-title":"Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863","volume":"3","author":"Johnson","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev"},{"issue":"17","key":"10.1016\/j.mam.2016.01.001_bib0400","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/MCB.00609-13","article-title":"Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice","volume":"33","author":"Kalucka","year":"2013","journal-title":"Mol. Cell. Biol"},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0405","doi-asserted-by":"crossref","first-page":"F1172","DOI":"10.1152\/ajprenal.00667.2011","article-title":"Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury","volume":"302","author":"Kapitsinou","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0410","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0003-2697(90)90683-Z","article-title":"Assay for 2-oxoglutarate decarboxylating enzymes based on the determination of [1-14C]succinate: application to prolyl 4-hydroxylase","volume":"184","author":"Kaule","year":"1990","journal-title":"Anal. Biochem"},{"issue":"17","key":"10.1016\/j.mam.2016.01.001_bib0415","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/cc.10.17.16745","article-title":"Mutations to metabolic enzymes in cancer herald a need to unify genetics and biochemistry","volume":"10","author":"Kawamura","year":"2011","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/mi.2013.29","article-title":"Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis","volume":"7","author":"Keely","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib0430","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/01.CIR.0000155608.07691.B7","article-title":"Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections","volume":"111","author":"Kempf","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mam.2016.01.001_bib0435","series-title":"Treatment Method for Anemia","author":"Klaus","year":"2006"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2143","article-title":"Regulation of histone methylation by demethylimination and demethylation","volume":"8","author":"Klose","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1016\/j.mam.2016.01.001_bib0445","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrg1945","article-title":"JmjC-domain-containing proteins and histone demethylation","volume":"7","author":"Klose","year":"2006","journal-title":"Nat. Rev. Genet"},{"issue":"10","key":"10.1016\/j.mam.2016.01.001_bib9025","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood-2007-06-094441","article-title":"Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor","volume":"110","author":"Koditz","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0450","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1074\/jbc.M312254200","article-title":"Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl-4-hydroxylases","volume":"279","author":"Koivunen","year":"2004","journal-title":"J. Biol. Chem"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0455","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1074\/jbc.M610415200","article-title":"Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF","volume":"282","author":"Koivunen","year":"2007","journal-title":"J. Biol. Chem"},{"issue":"7390","key":"10.1016\/j.mam.2016.01.001_bib0460","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0465","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrneph.2015.82","article-title":"Anaemia in kidney disease: harnessing hypoxia responses for therapy","volume":"11","author":"Koury","year":"2015","journal-title":"Nat. Rev. Nephrol"},{"issue":"7","key":"10.1016\/j.mam.2016.01.001_bib0470","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/ar700066p","article-title":"Non-heme Fe(IV)-oxo intermediates","volume":"40","author":"Krebs","year":"2007","journal-title":"Acc. Chem. Res"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0475","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"Kulshreshtha","year":"2007","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.mam.2016.01.001_bib0480","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/BJ20040735","article-title":"Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity","volume":"383","author":"Lancaster","year":"2004","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2006.09.170","article-title":"Analysis of HIF-prolyl hydroxylases binding to substrates","volume":"351","author":"Landazuri","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0490","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.mam.2016.01.001_bib0495","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib9030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","article-title":"A lactate-induced response to hypoxia","volume":"161","author":"Lee","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0500","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/1087057108318800","article-title":"Monoclonal antibody-based screening assay for factor inhibiting hypoxia-inducible factor inhibitors","volume":"13","author":"Lee","year":"2008","journal-title":"J. Biomol. Screen"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-9255-10-28","article-title":"Role of hypoxia inducible factor-1 in keratinocyte inflammatory response and neutrophil recruitment","volume":"10","author":"Leire","year":"2013","journal-title":"J. Inflamm"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0510","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/jm901537q","article-title":"Using NMR solvent water relaxation to investigate metalloenzyme-ligand binding interactions","volume":"53","author":"Leung","year":"2010","journal-title":"J. Med. Chem"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0515","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.chembiol.2010.09.016","article-title":"Structural and mechanistic studies on gamma-butyrobetaine hydroxylase","volume":"17","author":"Leung","year":"2010","journal-title":"Chem. Biol"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0520","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/jm301583m","article-title":"Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors","volume":"56","author":"Leung","year":"2013","journal-title":"J. Med. Chem"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0525","doi-asserted-by":"crossref","first-page":"e1004818","DOI":"10.1371\/journal.ppat.1004818","article-title":"Role of hypoxia inducible factor-1alpha (HIF-1alpha) in innate defense against uropathogenic Escherichia coli infection","volume":"11","author":"Lin","year":"2015","journal-title":"PLoS Pathog"},{"issue":"8823","key":"10.1016\/j.mam.2016.01.001_bib0530","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0535","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1023\/A:1005458703363","article-title":"From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug","volume":"21","author":"Lock","year":"1998","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1016\/j.mam.2016.01.001_bib0540","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nchembio0308-152","article-title":"Expanding chemical biology of 2-oxoglutarate oxygenases","volume":"4","author":"Loenarz","year":"2008","journal-title":"Nat. Chem. Biol"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0545","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2010.07.002","article-title":"Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases","volume":"36","author":"Loenarz","year":"2011","journal-title":"Trends Biochem. Sci"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0550","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/embor.2010.170","article-title":"The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens","volume":"12","author":"Loenarz","year":"2011","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib9035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0555","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0560","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MIB.0000000000000277","article-title":"Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis","volume":"21","author":"Marks","year":"2015","journal-title":"Inflamm. Bowel Dis"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0565","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-3002-2-3","article-title":"Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways","volume":"2","author":"Masson","year":"2014","journal-title":"Cancer Metab"},{"key":"10.1016\/j.mam.2016.01.001_bib0570","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ki.1993.362","article-title":"Identification of the renal erythropoietin-producing cells using transgenic mice","volume":"44","author":"Maxwell","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.mam.2016.01.001_bib0575","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1073\/pnas.90.6.2423","article-title":"Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen sensing mechanism","volume":"90","author":"Maxwell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0580","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.1997.387","article-title":"The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression","volume":"52","author":"Maxwell","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.mam.2016.01.001_bib0585","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0590","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000351175","article-title":"Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease","volume":"37","author":"McCullough","year":"2013","journal-title":"Am. J. Nephrol"},{"issue":"21","key":"10.1016\/j.mam.2016.01.001_bib0595","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1021\/ja050841b","article-title":"Selective inhibition of factor inhibiting hypoxia-inducible factor","volume":"127","author":"McDonough","year":"2005","journal-title":"J. Am. Chem. Soc"},{"issue":"26","key":"10.1016\/j.mam.2016.01.001_bib0600","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"McDonough","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0605","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.sbi.2010.08.006","article-title":"Structural studies on human 2-oxoglutarate dependent oxygenases","volume":"20","author":"McDonough","year":"2010","journal-title":"Curr. Opin. Struct. Biol"},{"issue":"Pt 3","key":"10.1016\/j.mam.2016.01.001_bib0610","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj20021162","article-title":"Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803","volume":"367","author":"McNeill","year":"2002","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0615","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ab.2004.09.019","article-title":"A fluorescence-based assay for 2-oxoglutarate-dependent oxygenases","volume":"336","author":"McNeill","year":"2005","journal-title":"Anal. Biochem"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0620","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/b511249b","article-title":"Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate","volume":"1","author":"McNeill","year":"2005","journal-title":"Mol. Biosyst"},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib0625","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J. Med. Chem"},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib9040","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/MCB.01231-07","article-title":"The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress","volume":"28","author":"Mikhaylova","year":"2008","journal-title":"Mol. Cell. Biol"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0630","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2007-10-117812","article-title":"Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure","volume":"111","author":"Minamishima","year":"2008","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.mam.2016.01.001_bib0635","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/MCB.00331-09","article-title":"A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo","volume":"29","author":"Minamishima","year":"2009","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.mam.2016.01.001_bib0640","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0960-894X(03)00539-0","article-title":"2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase","volume":"13","author":"Mole","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.mam.2016.01.001_bib9045","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/MCB.01457-14","article-title":"Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia","volume":"35","author":"Moore","year":"2015","journal-title":"Mol. Cell. Biol"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0645","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.abb.2004.08.015","article-title":"4-Hydroxyphenylpyruvate dioxygenase","volume":"433","author":"Moran","year":"2005","journal-title":"Arch. Biochem. Biophys"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib8010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.devcel.2013.06.014","article-title":"PHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192","volume":"26","author":"Moser","year":"2013","journal-title":"Dev. Cell"},{"issue":"1\u20132","key":"10.1016\/j.mam.2016.01.001_bib0650","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2013.06.018","article-title":"Oxygen tension level and human viral infections","volume":"444","author":"Morinet","year":"2013","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0655","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/apha.12096","article-title":"Prolyl 4-hydroxylases, master regulators of the hypoxia response","volume":"208","author":"Myllyharju","year":"2013","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0660","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri2607","article-title":"Interdependence of hypoxic and innate immune responses","volume":"9","author":"Nizet","year":"2009","journal-title":"Nat. Rev. Immunol"},{"issue":"45","key":"10.1016\/j.mam.2016.01.001_bib0665","doi-asserted-by":"crossref","first-page":"34503","DOI":"10.1074\/jbc.M110.156398","article-title":"Expanding role of the jumonji C domain as an RNA hydroxylase","volume":"285","author":"Noma","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0670","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/hc4301.097193","article-title":"Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction","volume":"104","author":"Nwogu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mam.2016.01.001_bib0675","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ab.2004.03.066","article-title":"A non-radioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity","volume":"330","author":"Oehme","year":"2004","journal-title":"Anal. Biochem"},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0680","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00109-012-0882-3","article-title":"A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection","volume":"90","author":"Okumura","year":"2012","journal-title":"J. Mol. Med"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0685","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1358863X14557151","article-title":"Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease","volume":"19","author":"Olson","year":"2014","journal-title":"Vasc. Med"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0690","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cvr\/cvu172","article-title":"HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore","volume":"104","author":"Ong","year":"2014","journal-title":"Cardiovasc. Res"},{"issue":"18","key":"10.1016\/j.mam.2016.01.001_bib0695","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1021\/bi501540c","article-title":"Increased turnover at limiting O2 concentrations by the Thr(387) \u2192 ala variant of HIF-prolyl hydroxylase PHD2","volume":"54","author":"Pektas","year":"2015","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0700","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejheart.2005.10.009","article-title":"Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats","volume":"8","author":"Philipp","year":"2006","journal-title":"Eur. J. Heart Fail"},{"issue":"15","key":"10.1016\/j.mam.2016.01.001_bib0705","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.mam.2016.01.001_bib0710","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BJ20081238","article-title":"Regulation of Jumonji-domain containing histone demethylases by hypoxia inducible factor (HIF) 1-alpha","volume":"416","author":"Pollard","year":"2008","journal-title":"Biochem. J."},{"issue":"46","key":"10.1016\/j.mam.2016.01.001_bib0715","doi-asserted-by":"crossref","first-page":"16654","DOI":"10.1021\/ja907933p","article-title":"Different modes of inhibitor binding to prolyl hydroxylase by combined use of X-ray crystallography and NMR spectroscopy of paramagnetic complexes","volume":"131","author":"Poppe","year":"2009","journal-title":"J. Am. Chem. Soc"},{"issue":"7092","key":"10.1016\/j.mam.2016.01.001_bib0720","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0725","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00030.2011","article-title":"Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2","volume":"92","author":"Prabhakar","year":"2012","journal-title":"Physiol. Rev"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0730","doi-asserted-by":"crossref","first-page":"e84767","DOI":"10.1371\/journal.pone.0084767","article-title":"Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke","volume":"9","author":"Reischl","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0735","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2007.09.033","article-title":"Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition","volume":"134","author":"Robinson","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0740","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.4049\/jimmunol.1103817","article-title":"Stabilization of HIF-2alpha induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model","volume":"189","author":"Roda","year":"2012","journal-title":"J. Immunol"},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib0745","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1039\/c0cs00203h","article-title":"Inhibition of 2-oxoglutarate dependent oxygenases","volume":"40","author":"Rose","year":"2011","journal-title":"Chem. Soc. Rev"},{"key":"10.1016\/j.mam.2016.01.001_bib0750","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1\u03b1 and -2\u03b1 in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0755","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/ndt\/gfn276","article-title":"Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney","volume":"23","author":"Rosenberger","year":"2008","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.mam.2016.01.001_bib0760","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0765","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1515\/hsz-2012-0351","article-title":"Pan-genomic binding of hypoxia-inducible transcription factors","volume":"394","author":"Sch\u00f6del","year":"2013","journal-title":"Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0770","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V73.1.13.13","article-title":"Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure","volume":"73","author":"Schuster","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0775","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2016.01.001_bib0780","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1128\/MCB.12.12.5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell. Biol"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0785","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.gastro.2013.12.031","article-title":"Hypoxia-inducible factors link iron homeostasis and erythropoiesis","volume":"146","author":"Shah","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0790","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/02713689309001833","article-title":"In vitro inhibition of collagen formation by 2,4-pyridine dicarboxylate and minoxidil in rabbit corneal fibroblasts","volume":"12","author":"Sharir","year":"1993","journal-title":"Curr. Eye Res"},{"issue":"50","key":"10.1016\/j.mam.2016.01.001_bib0795","doi-asserted-by":"crossref","first-page":"41732","DOI":"10.1074\/jbc.M504963200","article-title":"Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system","volume":"280","author":"Siddiq","year":"2005","journal-title":"J. Biol. Chem"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0800","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-2952(88)90717-4","article-title":"3-(2,2,2-Trimethylhydrazinium)propionate (THP)\u2013a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties","volume":"37","author":"Simkhovich","year":"1988","journal-title":"Biochem. Pharmacol"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0805","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev"},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0810","doi-asserted-by":"crossref","first-page":"e38489","DOI":"10.1371\/journal.pone.0038489","article-title":"Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0815","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.chembiol.2010.03.008","article-title":"Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation","volume":"17","author":"Smirnova","year":"2010","journal-title":"Chem. Biol"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib0820","doi-asserted-by":"crossref","first-page":"e88955","DOI":"10.1371\/journal.pone.0088955","article-title":"Proline-hydroxylated hypoxia-inducible factor 1alpha (HIF-1alpha) upregulation in human tumours","volume":"9","author":"Snell","year":"2014","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.mam.2016.01.001_bib0825","doi-asserted-by":"crossref","first-page":"14656","DOI":"10.1074\/jbc.M113.541227","article-title":"Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing","volume":"289","author":"Song","year":"2014","journal-title":"J. Biol. Chem"},{"issue":"10","key":"10.1016\/j.mam.2016.01.001_bib0830","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2013010030","article-title":"Plasticity of renal erythropoietin-producing cells governs fibrosis","volume":"24","author":"Souma","year":"2013","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1016\/j.mam.2016.01.001_bib0835","article-title":"Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling","author":"Souma","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"issue":"9","key":"10.1016\/j.mam.2016.01.001_bib0840","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1021\/jm900285r","article-title":"Application of a proteolysis\/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure","volume":"52","author":"Stubbs","year":"2009","journal-title":"J. Med. Chem"},{"issue":"37","key":"10.1016\/j.mam.2016.01.001_bib0845","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1073\/pnas.1515872112","article-title":"Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle","volume":"112","author":"Suhara","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.mam.2016.01.001_bib0850","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-[alpha] dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.mam.2016.01.001_bib9050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio.640","article-title":"TRPA1 underlies a sensing mechanism for O2","volume":"7","author":"Takahashi","year":"2011","journal-title":"Nat. Chem. Biol"},{"issue":"5","key":"10.1016\/j.mam.2016.01.001_bib0855","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","article-title":"Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis","volume":"24","author":"Takeda","year":"2010","journal-title":"Genes Dev"},{"issue":"7371","key":"10.1016\/j.mam.2016.01.001_bib0860","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature10507","article-title":"Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis","volume":"479","author":"Takeda","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0865","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20140779","article-title":"Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen","volume":"463","author":"Tarhonskaya","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.mam.2016.01.001_bib0870","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/ncomms4423","article-title":"Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases","volume":"5","author":"Tarhonskaya","year":"2014","journal-title":"Nat. Commun"},{"issue":"32","key":"10.1016\/j.mam.2016.01.001_bib0875","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1074\/jbc.M115.653014","article-title":"Kinetic investigations of the role of factor inhibiting hypoxia-inducible factor (FIH) as an oxygen sensor","volume":"290","author":"Tarhonskaya","year":"2015","journal-title":"J. Biol. Chem"},{"issue":"2\u20133","key":"10.1016\/j.mam.2016.01.001_bib0880","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ddstr.2012.02.002","article-title":"The potential of 2-oxoglutarate oxygenases acting on nucleic acids as therapeutic targets","volume":"9","author":"Thalhammer","year":"2012","journal-title":"Drug Discov. Today Ther. Strateg"},{"key":"10.1016\/j.mam.2016.01.001_bib0885","article-title":"Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls","author":"Thevis","year":"2015","journal-title":"Drug Test. Anal"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0890","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbagrm.2014.05.009","article-title":"Targeting histone lysine demethylases \u2013 progress, challenges, and the future","volume":"1839","author":"Thinnes","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.mam.2016.01.001_bib0895","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1074\/jbc.M110.211110","article-title":"Differential sensitivity of HIF hydroxylation sites to hypoxia and hydroxylase inhibitors","volume":"286","author":"Tian","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mam.2016.01.001_bib0900","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/bj2750469","article-title":"Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor","volume":"275","author":"Tschank","year":"1991","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0905","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMp0912328","article-title":"Erythropoiesis-stimulating agents \u2013 time for a reevaluation","volume":"362","author":"Unger","year":"2010","journal-title":"NEJM"},{"issue":"7401","key":"10.1016\/j.mam.2016.01.001_bib0910","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature11055","article-title":"An oxygen-regulated switch in the protein synthesis machinery","volume":"486","author":"Uniacke","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mam.2016.01.001_bib0915","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-014-1667-z","article-title":"Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult","author":"Vogler","year":"2015","journal-title":"Pfl\u00fcgers Arch"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0920","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood.V82.12.3610.3610","article-title":"Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction","volume":"82","author":"Wang","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.mam.2016.01.001_bib0925","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0930","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/ndt\/gfr379","article-title":"The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment","volume":"27","author":"Wang","year":"2012","journal-title":"Nephrol. Dial. Transplant"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0935","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1524-475X.2011.00697.x","article-title":"Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure","volume":"19","author":"Wetterau","year":"2011","journal-title":"Wound Repair Regen"},{"issue":"12","key":"10.1016\/j.mam.2016.01.001_bib0940","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1074\/jbc.M111.294678","article-title":"Factor inhibiting HIF (FIH) recognises distinct molecular features within hypoxia inducible factor (HIF)-alpha versus ankyrin repeat substrates","volume":"287","author":"Wilkins","year":"2012","journal-title":"J. Biol. Chem"},{"issue":"1","key":"10.1016\/j.mam.2016.01.001_bib0945","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yjmcc.2006.04.009","article-title":"HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation","volume":"41","author":"Willam","year":"2006","journal-title":"J. Mol. Cell. Cardiol"},{"issue":"3","key":"10.1016\/j.mam.2016.01.001_bib0950","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archinte.1954.00240270073007","article-title":"Treatment of sickle cell anemia with cobalt chloride","volume":"93","author":"Wolf","year":"1954","journal-title":"Arch. Intern. Med"},{"issue":"7565","key":"10.1016\/j.mam.2016.01.001_bib0955","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature14883","article-title":"Structural integration in hypoxia-inducible factors","volume":"524","author":"Wu","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.mam.2016.01.001_bib0970","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1073\/pnas.0810067106","article-title":"Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis","volume":"106","author":"Xia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.mam.2016.01.001_bib9055","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1172\/JCI62374","article-title":"PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response","volume":"122","author":"Xie","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"78","key":"10.1016\/j.mam.2016.01.001_bib9060","doi-asserted-by":"crossref","first-page":"ra33","DOI":"10.1126\/scisignal.2000444","article-title":"Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL","volume":"2","author":"Xie","year":"2009","journal-title":"Sci. Signal"},{"issue":"2","key":"10.1016\/j.mam.2016.01.001_bib9065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2011.05.012","article-title":"Prolyl hydroxylase domain protein 3 targets Pax2 for destruction","volume":"409","author":"Yan","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.mam.2016.01.001_bib0975","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1021\/ja004025+","article-title":"Spectroscopic studies of substrate interactions with clavaminate synthase 2, a multifunctional alpha-KG dependent non-heme iron enzyme: correlation with mechanisms and reactivities","volume":"123","author":"Zhou","year":"2001","journal-title":"J. Am. Chem. Soc"},{"issue":"4","key":"10.1016\/j.mam.2016.01.001_bib0980","doi-asserted-by":"crossref","first-page":"e93373","DOI":"10.1371\/journal.pone.0093373","article-title":"Epidermal or dermal specific knockout of PHD-2 enhances wound healing and minimizes ischemic injury","volume":"9","author":"Zimmermann","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299715300169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299715300169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T20:59:45Z","timestamp":1600030785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299715300169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":207,"alternative-id":["S0098299715300169"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2016.01.001","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological targeting of the HIF hydroxylases \u2013 A new field in medicine development","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}